Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
20.40
+0.26 (1.29%)
Nov 21, 2024, 2:00 PM EST - Market open
Avantor Revenue
Avantor had revenue of $1.71B in the quarter ending September 30, 2024, a decrease of -0.34%. This brings the company's revenue in the last twelve months to $6.82B, down -3.12% year-over-year. In the year 2023, Avantor had annual revenue of $6.97B, down -7.26%.
Revenue (ttm)
$6.82B
Revenue Growth
-3.12%
P/S Ratio
2.00
Revenue / Employee
$900,898
Employees
7,570
Market Cap
13.88B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG | 21.46B |
Tenet Healthcare | 20.97B |
Universal Health Services | 15.42B |
Viatris | 15.05B |
Moderna | 5.08B |
Incyte | 4.08B |
Genmab | 2.97B |
Revvity | 2.72B |
AVTR News
- 1 day ago - Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference - PRNewsWire
- 1 day ago - Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology - Business Wire
- 7 days ago - Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges - PRNewsWire
- 15 days ago - Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors - PRNewsWire
- 27 days ago - Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Avantor® Reports Third Quarter 2024 Results - PRNewsWire
- 4 weeks ago - Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges - PRNewsWire
- 4 weeks ago - Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions - Business Wire